Canada Dermatology Market

Canada
Dermatology
Market Analysis
Includes Market Size, Market Segmented by Types
and Key Competitors (Data forecasts from 2021 – 2030)
www.insights10.com

3 A Sample Report on Canada Dermatology Market I Confidential
Table of Contents
1. Methodology and Scope…………………………………………………………………….…………………………………………………..….07
1.1 Research Methodology
1.2 Analysis Methodology
1.3 Research Approach
1.4 Key benefits for stakeholders from this report
2. Canada Dermatological Therapeutics Market Overview…………………………………………………………………………………..….12
2.1 Market Size
2.2 Market size and forecast
3. Market Growth Drivers and Restraints …………………………………………………………………….……………………………………15
3.1 Market Growth Drivers
3.1.1 Growing Burden of Dermatology Diseases
3.1.2 Increase in Awareness Levels of Disease Progression and Etiology
3.1.3 Technological advancements in dermatology devices
3.1.4 Technological advancements in dermatology devices
3.1.5 Growing awareness of cosmetics procedures to improve the aesthetic appeal
3.1.6 Increase in number of approval for Dermatology Products
3.1.7 Growing need for rapid diagnosis and treatment of skin disorders

Table of Contents (continued)
3.2 Market Restraints
3.2.1 Availabilities of alternatives for treatment
3.2.2 Side Effects Associated with Drugs
3.2.3 Stringent Government regulations and High cost of dermatology drugs
4. Major Dermatological Diseases…..……………………………………………………………………………………..………………………..24
4.1 Alopecia
4.2 Herpes
4.3 Psoriasis
4.4 Rosacea
4.5 Atopic Dermatitis
4.6 Eczema
4.7 Hyperhidrosis
4.8 Others

5. Dermatological Therapeutics Market Segmentation……………………………………………………………………………………….….27
5.1 By Disease Type
5.1.1 Acne
5.1.2 Dermatitis
5.1.3 Psoriasis
5.1.4 Skin Cancer
5.1.5 Rosacea
5.1.6 Alopecia
5.2 By Drug Class
5.2.1 Anti-infectives
5.2.2 Corticosteroids
5.2.3 Calcineurin Inhibitors
5.2.4 Retinoids
5.2.5 Antirheumatic
5.2.6 Others
5.3 By Route of Administration
5.3.1 Oral
5.3.2 Topical
5.3.3 Parenteral Administration
5.4 By End Users
5.4.1 Home Care
5.4.2 Hospitals
5.4.3 Dermatology Clinics
5.5 By Distribution Channel
5.5.1 Pharmacy Store
5.5.2 Retail Store
5.5.3 Online
5.5.4 Supermarkets/Hypermarkets

6. Dermatology Major Products Market Share……………………………………………………………………………...…………..….......……34
6.1 Market Analysis, Insights and Forecast - By Revenue
7. Competitive Landscape……………………………………………………………………………………………………….…………………...….36
7.1 Major Player
7.2 Products in Pipeline
8. Key Company Profiles (Company Overview, Product & Services, Strategies & Financials ) ….…………………………………………......39
8.1 AbbVie
8.2 Bausch Health Ltd.
8.3 Johnson & Johnson Services, Inc
8.4 GlaxoSmithKline Plc
8.5 Dermtek Pharma
8.6 Stiefel
8.7 Galderma
9. Healthcare Policies and Regulatory Landscape………………………………….………………………………………………………………54
9.1 Policy changes and Reimbursement scenario
10. Factors Driving Future Growth……………………………………………………………………………………………………………….…….56

A Sample Report on Canada Dermatology Market
Methodology and Scope

Research Methodology
 Insights 10’s research methodology delves deep into the market, covering the macro and micro aspects of the industry. We identify the
key growth drivers, opportunities, and restraints that might promote or hinder the future industry growth along with an expansive
overview of the competitive landscape to help our clients make informed strategic decisions
 We implement a mix of primary and secondary research for our market estimate and forecast. The secondary research forms the initial
phase of our study where we conducted extensive data mining, referring to verified data sources such as independent studies,
government and regulatory published material, technical journals, trade magazines, and paid data sources
 For forecasting, the following parameters were considered:
 Market drivers and restraints along with their current and expected impacts
 Technological scenario and expected developments
 End use industry trends and dynamics
 Trends in the consumer behavior
 Regulatory scenario and expected developments
 Current capacity and expected capacity additions up to 2030
 We have assigned weights to these parameters and quantified their market impacts using the weighted average analysis to derive the
expected market growth rate
 We appoint data triangulation strategies to explore different areas of the market. Our qualitative and quantitative assessments are time-
sensitive, reflecting the most recent value and volume of the market across regions
 All our estimates and forecasts were verified through exhaustive primary research with the Key Industry Participants (KIPs)

Analysis Methodology
• Final Market Size Break-up to Rest of
Segmentation i.e., Product and Services,
Type, Specialty, Delivery Mode and
Geography, etc
• Arriving at the Market Size of each Segment
• Data Validation with Primary Interviews
• Final Market Size
• Validation from Primary Interview
• Summation of Revenue Generated from
Companies to Arrive at Total Market Size
• Revenue Generated by Products and
Services offered by Companies
Top Down Analysis
Bottom-up Analysis

Research Approach
The data presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
Data Collection
• Primary Interviews (Industry Participants,
Outside experts)
• Secondary Data
Company Reports and Publications,
Government Data, Financial Reports of Key
Industry Players, Press Releases, Scientific
and Industry Publications and Whitepapers
Market Data Analysis &
Statistical Model
• Market Trends
• Market Sizing and Analysis
• Data Triangulation & Validation
Market Trends such as Drivers, Restraints,
Opportunities, Challenges. An intensive
cross-verification and validation process
Interpretation and
Presentation
• Analysis & Interpretation
• Insights
• Presentation & Reporting
The information gathered is then analyzed
and synthesized. The market research
report is presented in different forms such
as charts by using a scientific approach for
easy understanding

Key Benefit for Stakeholders from this report
The study provides an in-depth analysis of the Canada Dermatology Market Analysis with current trends and future estimations
to elucidate the imminent investment pockets
Our tools provides stakeholders with a cohesive understanding of the industry outlook, considering the qualitative and
quantitative industry variables
Comprehensive analysis of factors that drive and restrict the market growth is provided
Comprehensive quantitative analysis of the industry from 2021 to 2030 is provided to enable the stakeholders to capitalize on
the prevailing market opportunities
Extensive analysis of the key segments of the industry helps understand the applications and technologies used globally
Our rigorous data collection, thorough statistical analysis and specialist assessments ensure that our clientele has a greater
understanding of the industry space, supply chain, price fluctuations, competitive landscape, and other vital factors

Canada Dermatology Market Analysis:
Market Overview

85% of younger individuals suffers from skin disease according to
American Association of Dermatology
 Dermatology is the branch of medicine dealing with
skin and skin diseases like acne, atopic dermatitis,
skin cancer, and psoriasis.
 A dermatologist is a doctor who specializes in
conditions affecting the hair, skin, and nails.
 According to the American Academy of
Dermatology Association, a dermatologist can
identify and treat approximately 3,000 skin-related
diseases.
 The skin serves as a body barrier, protecting
internal organs from microbes and damage.
 Dermatologic problems are associated, and almost
everyone experiences symptoms of one or more of
them at some point in their lives.

Canada Dermatology Market Analysis (Current and Forecast)
Canada Dermatology Market Size (Bn) 2021-2030F
 Canadian dermatological therapeutics market size
stood at around USD 225.90 million in 2021 and is
projected to reach USD 24.853 billion by 2030,
exhibiting a CAGR of 3% during the forecast period.
 More Canadians are investing in their skincare and
the market is driven by an aging population looking
for solutions to maintaining healthy skin and
younger
 Technological advancements and the increasing
prevalence of skincare are anticipated to fuel the
growth
Key Analysis
32
24.853
2021 2022F 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F

Growth Drivers and Growth Restraints

Market Growth Drivers
Growing need for rapid diagnosis and
treatment of skin disorders
Increase in number of approval
for Dermatology Products
Increase in awareness levels of
disease progression and Etiology
Growing Burden of
Dermatology Diseases
Growing awareness of cosmetics
procedures to improve the aesthetic appeal
Technological advancement
in Dermatology Devices

Market Growth Drivers
In Canada, 20% of the population has acne issues,1 million Canadian have been diagnosed with psoriasis, 2 million
Canadians have rosacea and 90%% skin cancer curate if self diagnosed
1. Growing Burden of Dermatology Diseases
Sample
Canada’s market is majorly driven by the rising burden of dermatology diseases. The skincare market is driven by the
consumer attitude that is, to improve their quality of life in terms of looks and this attitude is visible across all the age groups

Market Growth Drivers (continued)
2. Increase in Awareness Levels of Disease Progression and Etiology
#StopWaiting and get that mole checked out this is the campaign in Canada to make people aware about the diseases.
The campaign is geared to raise awareness about skin diseases and skin cancers, all while providing Canadians an option
to have their suspicious moles analyzed by artificial intelligence and confirmed by doctors through the new Get Skin Help
mobile app
Melanoma and skin cancer screening are not top of mind. Regular skin-checks do not get the same consideration as
mammograms, PSA tests and other cancer screenings
Sample

3. Technological advancement in Dermatology Devices
As the scope of Dermatology Drugs research and application proliferates, the market will see greater integration and
application of more technologies in the future
The widespread availability of Dermatology Drugs is helping to accelerate business digitalization, improve industry chain
structures, and improve information use efficiency
Sample

4. Growing awareness of cosmetics procedures to improve the aesthetic appeal
Rising personal grooming expenditure is a critical factor driving market growth, as is rising awareness of skin disease, a
rise in the number of patients with severe from acne, vitiligo, and dermatitis
Sample
Rising demand for effective products to cure skin disorders and disorders, rising awareness among the young population,
rising demand for effective dermatological treatments, and an increase in the number of companies investing in the market

5. Growing need for rapid diagnosis and treatment of skin disorders
Increase in number of clinical studies for evaluating safety and efficiency of a wide range of therapeutic drugs is
anticipated to contribute toward growth of the dermatological market
Sample
Sample

6. Increase in number of approval for Dermatology Products
The increase in the number of dermatological drugs approved drives market growth
Sample
For instance, AbbVie Inc., a pharmaceutical company, announced in December 2021 that Rinvoq (upadacitinib) had
received FDA approval for the treatment of patients with active psoriatic arthritis. This medication is recommended for
patients who have an intolerance to or an inadequate response to tumour necrosis factor blockers

Aavailabilities of alternatives for
treatment
Side Effects Associated with
Drugs
Market Restraints
 The pharmacotherapy received by a
large proportion of dermatology in
Canada differs from what one would
normally expect
 This deviation is relevant not only
because of the costs of the drugs, but
also because of the significant potential
side effects associated with different
dermatology drugs
Sample
Stringent Government regulations
and High cost of dermatology drugs
 Retail prices of brand-name prescription
drugs for dermatologic conditions ranging
from acne to cancer increased fivefold on
average between in last 10 years
 High cost adds new fuel to the burgeoning
debate over the cost of medicines.
 FDA regulates dermatology drugs under
the Federal Food, Drug and Cosmetic Act
(FD&C Act)
 Under FD&C Act dermatology drugs must
not be adulterated or misbranded. They
must be safe for consumers under labeled
or customary conditions of use, and they
must be properly labeled.

Major Dermatological Diseases

Alopecia Herpes
As many as one in seven
Canadians aged 14 to 59
may be infected with
herpes simplex type 2
virus and more than 90
per cent of them may be
unaware of their status.
Psoriasis Rosacea
Approximately 2 million
Canadians, about 6 per
cent of the population, have
rosacea. People between the
ages of 30 and 60 years are
most typically affected. It is
most common in women and
people with fair skin. Up to 40
per cent of affected men and
women have a family
member with rosacea
In Canada, the annual
years of healthy life lost
per 100,000 people from
Alopecia Areata has
increased by 10.7% since
1990, an average of 0.5%
a year.
Psoriasis affects 1
million Canadians and
125 million people
worldwide. The most
common form is plaque
psoriasis, which affects
approximately 90% of
patients. Up to 30% of
patients with psoriasis
have or will have arthritis.

Sample
Atopic Dermatitis Eczema Hyperhidrosis
Atopic Dermatitis (AD) is
hereditary and the most
common type of eczema. It is
estimated that up to 17 per
cent of Canadians will
suffer from AD at some
point in their lives. AD
almost always starts in
infancy or before age 5
Hyperhidrosis is a disorder
that defines individuals who
sweat more than the body
would normally need to
maintain optimal
temperature. It affects
approximately 3% of the
population – some 950,000
Canadians – of whom
300,000 have a severe form
of the disorder.

Market Segmentation

28
Snapshot of Dermatology Market Segmentation
Market Segmentation
By Drug Class
By Disease Type
By Route of
Administration
Topical
Parenteral
Administration
Oral Home Care
Retinoids
Calcineurin
Inhibitors
Corticosteroids
Acne
Dermatitis
Psoriasis
Skin Cancer
Rosacea Antirheumatic
Alopecia
Anti-infectives
By End-Users
Hospitals
Dermatology
Clinics
By Distribution
Channel
Online
Retail Store
Pharmacy Store
Supermarkets

29
 Acne affects 5.6 million Canadians, nearly 20 per cent of
the population. More than 80 per cent of acne sufferers
are between ages 12 and 24. Acne affects about 90 per
cent of adolescents, and 20-30 per cent of adults ages 20
to 40.
 It is estimated that up to 17 per cent of Canadians will
suffer from AD at some point in their lives
 Over 80,000 cases of skin cancer are diagnosed in
Canada each year, more than 5,000 of these are
melanoma, the deadliest form of skin cancer, and
Rosacea affects more than 3 million Canadians.
 2% of the population of Canada in some form over their
lifetime. Alopecia totalism is a more severe form of
alopecia areata marked by total hair loss on the scalp. It
results in complete scalp baldness.
Market Segmentation: By Disease Type
Canada Dermatology Market Share by Disease type 2022
Key Insights
Dermatology Diseases
Acne Dermatitis Psoriasis
Skin Cancer Rosacea Alopecia

 Based on drug class, Canada’s dermatological market can
be segmented into anti-infectives, corticosteroids,
calcineurin inhibitors, retinoids, and other drug classes.
And few drugs are reimbursed across the Canadian
market.
 For instance, recently Abbvie’s Skyrizi (an interleukin
inhibitor) for the treatment of moderate to severe plaque
psoriasis is now publicly reimbursed
Market Segmentation: By Drug Type
Canada dermatology Market Share by Drug Type 2021
Key Insights
Anti-infectives Corticosteroids
Calceneurin Inhibitors Retinoids
Antirhematic

31
Market Segmentation: Route of Administration
Key Assumptions
Route of Administration
Topical Oral Parenteral administration
 By route of administration the Canada dermatology
market segmented in to topical drugs, Oral drugs and
Parenteral drugs
 Topical segment dominate the North America
dermatology drugs market due to majority of dermatology
drugs that are available in cream, gels, ointment and
others.
Canada dermatology Market Share by Route of
Administration 2021

32
Market Segmentation: By End Users
Canada Dermatology Market Share by End Users 2022
 The Canada Dermatology Market is segmented into
Homecare, Hospitals , and Dermatology Clinics, by the
End Users
Key Insights
End Users
Hospitals Homecare Dermatology Clinics

Market Segmentation: By Distribution Channels
Canada Dermatology Market Share by Distribution
Channel 2021
 Based on the distribution channel, the derma market is
classified into pharmacies and retail stores, online,
supermarkets/hypermarkets, etc. Of these, it is expected
that the pharmacy and retail store category will lead
throughout the forecast period.
 This is due to the availability of a broad range of over-the-
counter derma products, which are available in the
pharmacy and retail stores.
 However, with the increasing trend toward online shopping
and due to Covid-19 impact, people are preferring to make
an online purchase and due to this online category is also
witnessing faster growth in the derma market
Key Insights
Pharmacy Store
Retail store
Online
Supermarkets/ Hypermarlets

Major Products Market Share

Market Analysis, Insights and Forecast- By Major Brands
Key Insights
Canada Dermatology Market Analysis for Major
Brands 2021
Sample
Brand 1 Brand 2 Brand 3 Brand 4 Brand 5

Competitive Landscape

Competitive Landscape: Key Players Revenue (Current and Forecast)
Major Market Revenue of Top Companies in the Dermatology Market ($Mn)
2021 2022F 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
Abbvie Inc. $4500M - - - - - - - -
Bausch Health Ltd. $8400M - - - - - - - -
Johnson & Johnson
Services, Inc.
$xx - - - - - - - -
GlaxoSmithKline Plc. $xx - - - - - - - -
Dermtek Pharma $xx - - - - - - - -
Stiefel Company $xx - - - - - - - -
Galderma Company $xx - - - - - - - -

Competitive Landscape: Key Players Market Share
• Johnson & Johnson Consumer Health is ideally
positioned improve personal health by delivering
products that are scientifically based and
professionally endorsed
• AbbVie's identity is shaped by the work they do,
which involves establishing innovative medicines,
continuously making an investment in
their pipeline, and giving back to help communities
become healthier and more vibrant. Most
importantly, this identity has been shaped by the
shared beliefs that have emerged organically since
AbbVie's inception.
Key Insights
Major Market Share
AbbVie
Johnson and Johnson
Bausch Health Ltd
Others

Key Company Profiles

1. AbbVie Inc.
Company Name: AbbVie Inc.
Year of Establishment: 2013
Headquarter: United States of America
Total Revenue: $4500 M
Revenue from Dermatology: $y M
Website: http://www.abbvie.com
Sample
Company at a Glance
Business Overview

1. AbbVie Inc. (continued)
Sample
Breakdown of revenue (%) by segment, 2020
Total Revenues ($Mn), 2022-2030
Recent News and Developments
2022 2023 2024 2025 2026 2027 2028 2029 2030

2. Bausch Health Ltd.
Company Name: Bausch Health Ltd.
Headquarter: Canada
Total Revenue: $x M
Website: https://www.bauschhealth.com/
Sample
Company at a Glance
Business Overview

2. Bausch Health Ltd. (continued)
Sample
2022 2023 2024 2025 2026 2027 2028 2029 2030

3. Johnson & Johnson Services Inc.
Company Name: Johnson & Johnson
Headquarter: US
Total Revenue: $x M
Website: https://www.haemonetics.com/
Sample
Company at a Glance
Business Overview

3. Johnson & Johnson (continued)
 Johnson & Johnson Consumer Health Unveils New Skin Health Research at 2022 American Academy of
Dermatology Meeting.
 Janssen Initiates First-of-its-Kind Clinical Study to Bridge Critical Gaps in Care for People of Color with Moderate to
Severe Plaque Psoriasis
2022 2023 2024 2025 2026 2027 2028 2029 2030

4. GlaxoSmithKline
Company Name: GlaxoSmithKline
Headquarter: United Kingdom
Total Revenue: $x M
Website: https://www.gsk.com/
Sample
Company at a Glance
Business Overview

4. GlaxoSmithKline (continued)
Sample
2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030

Dermtek Pharma
Company Profile
 A leader in therapeutic dermatology in Canada, Dermtek
Pharma has developed more than thirty products, ten of
which are over-the-counter specialized treatment products,
especially formulated to meet the requirements of
dermatologists and consumers
 A well-known figure in the specialty of Dermatology in
Canada, Robert received the Healthcare Marketing Hall of
Fame Award in 2004 and in 2016 was given the Award of
Honour for his contributions to the overall well-being of
Canadians by the CDA (Canadian Dermatology Association)
Company Name: Dermtek Pharma
Headquarter: Quebec, Canada
Revenue: $2 million
Website: http://www.dermtek.com

Dermtek Pharma (continued)
Breakdown of net revenue by segment, 2020
Analysis
2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Sample

Sample
Company Name: Stiefel Company
Headquarter: North Carolina, United States
Revenue: $1.5 Bn
Website: https://www.stiefel.com//
Company Profile
Stiefel

Breakdown of net revenue (%) by segment, 2020
Sample
Stiefel (continued)
2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Analysis

Sample
Company Name: Galderma Company
Headquarter: Lausanne, Switzerland
Revenue: $3.417 Bn
Website: http://www.galderma.com/
Galderma
Company Profile

Breakdown of net revenue (%) by segment, 2020
Sample
Galderma (continued)
Analysis
2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030

Healthcare Policy and Regulatory Landscape

 The Canadian Dermatology Association, founded in 1925, represents Canadian dermatologists. The association
exists to advance the science and art of medicine and surgery related to the care of the skin, hair and nails;
provide continuing professional development for its members; support and advance patient care; provide public
education on sun protection and other aspects of skin health; and promote a lifetime of healthier skin, hair and
nails
 The mission of the Canadian Hidradenitis Suppurativa Foundation is to improve the daily life and quality of care
for Canadians living with Hidradenitis Suppurativa through education, research and patient empowerment
 The Canadian Working Group of Rheumatologists and Dermatologists (CARD) is supported by the Canadian
Dermatology Association. It functions independently and does not report to the CDA Board of Directors
 Initiatives taken by government and private organizations to develop pharmaceutical industry propel the growth
of the market. However, the presence of alternative for acne treatment such as light or lasers therapies,
chemical peels, micro needling, micro dermabrasion, and lesion removal is expected to restrict the
dermatological market growth during the forecast period
Policy Changes and Reimbursement Scenario in Canada Dermatology Market
Sample

Factors Driving Future Growth

Future Opportunities
Canadians who download the GetSkinHealth app and take pictures of their skin condition will get a pixel-by-pixel
Artificial Intelligence (AI) analysis that will look for the presence of skin diseases
Canadian medical technology company, will soon release a revolutionary skin disease mobile app
Sample
Sample
Sample
Sample

Canada Dermatology market is growing and
presents lucrative market opportunity
1
2
3
5
4
Technology
Advancement
Technological
advancements and the
increasing prevalence
of skincare are
anticipated to fuel the
growth
Internet
The introduction and
popularization of the Internet
have further accelerated the
pace of ICT advancements
Growing Burden
In Canada, 20% of the population has
acne issues, 1 million Canadian have
been diagnosed with psoriasis, 2 million
Canadians have rosacea and 90%% skin
cancer curate if self diagnosed
Policies
International Hyperhidrosis Society
mission is to reduce the symptoms,
anxiety, and social stigma
Future Opportunities
Canadian medical
technology company, will
soon release a
revolutionary skin disease
mobile app

email: info@insights10.com
www.insights10.com

Canada Dermatology Market

Recommended

Recommended

More Related Content

Similar to Canada Dermatology Market

Similar to Canada Dermatology Market (20)

More from Insights10

More from Insights10 (20)

Recently uploaded

Recently uploaded (20)

Canada Dermatology Market